Filtered By:
Condition: Babies Heart Conditions
Vaccination: Vaccines
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 22 results found since Jan 2013.
10 Good Reasons To Get A Flu Shot
By Melaina Juntti for Men's Journal
How many times have you heard you should get a flu shot? There's good reason for the hype: Over the past few years, the influenza vaccine has prevented millions of flu cases and tens of thousands of related hospitalizations, according to Centers for Disease Control and Prevention.
Although an increasing number of people are getting vaccinated every year, more than half of American men still aren't doing it, for a variety of reasons, most of which aren't backed by science. "Men have this macho sense that if they do get the flu, they can tough it out," says William Schaffner, M.D., chair...
Source: Healthy Living - The Huffington Post - November 29, 2014 Category: Consumer Health News Source Type: news
Every day, thousands of Americans turn 65. How do we help ensure that the U.S. system is ready to meet their needs?
Thumbnail: Tags: conversationsphrma conversationsMedicareseniorsmary grealybob blancatofreda lewis hallconversations 2Contributors: 118611871184Contributions: Read Freda Lewis-Hall's bio
The most impactful action we can take is to move to a prevention-centered system, with policies and programs in place to preserve good health and prevent disabling disease. There is no reason why age 65 shouldn’t be the gateway to years of general good health. We have to get people in the Baby Boom generation thinking now about how they can stay vigorous and delay, for as long as possible, the issues that come when...
Source: PHRMA - July 2, 2013 Category: Pharmaceuticals Authors: Stephen Source Type: news
Flu and freezing weather may be driving up winter death rates
Conclusion
There are always more deaths in winter than other seasons, particularly among elderly people. But why these fairly dramatic spikes in the death rate have occurred is still not understood.
It should be noted these figures are provisional, as there can be a delay in the ONS receiving the data.
Although the media has focused on the likely cause being flu, the numbers provided are for all respiratory conditions. Cold weather can exacerbate many of these conditions, such as asthma and chronic obstructive pulmonary disease.
For most fit and healthy people, flu is not a serious threat, but the elderly and those with...
Source: NHS News Feed - February 4, 2015 Category: Consumer Health News Tags: Heart/lungs Lifestyle/exercise Medical practice QA articles Source Type: news
10 Global Health Issues to Watch in 2018
January 19, 2018It ’s notallbad news.When we set out to compile our annual list of global health issues to watch this year, it seemed like all bad news. And true, that ’s often what we deal with in global health—the problems that need tackling, the suffering we can help alleviate.But then stories and columns likethis one cheer us up. They remind us that no matter how complicated and frustrating our work may get, fighting back against poverty and inequality works.There are and always will be global health challenges to face. But there ’s boundless hope, too. And a field full of determined health workers and other hu...
Source: IntraHealth International - January 19, 2018 Category: International Medicine & Public Health Authors: mnathe Source Type: news
Janssen Announces U.S. FDA Approval of INVEGA HAFYERA ™(6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia
TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia in adults. Before transitioning to INVEGA HAFYERA™, patients must be adequately treated with INVEGA SUSTENNA® (1-month paliperidone palmitate) for at least four months, or INVEGA TRINZA® (3-month paliperidone palmitate) for at least one 3-month injection cycle.1 The FDA approval of INVEGA ...
Source: Johnson and Johnson - September 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Stewardship for Science and Vaccines
Despite the success of vaccines in the modern world, including the rapid development of the COVID-19 vaccine, my state is now experiencing a large measles outbreak and a decline in immunization rates. At the turn of the century, the Centers for Disease Control and Prevention published “Ten Great Public Health Achievements” of the twentieth century in the United States.1 Vaccination topped the list, a national and global success story. Other achievements included improvements in motor-vehicle safety, control of infectious diseases, safer workplaces, decline in deaths from coro nary heart disease and stroke, safer and he...
Source: Pediatric Clinics of North America - February 24, 2023 Category: Pediatrics Authors: Tina L. Cheng Tags: Foreword Source Type: research
